1. Home
  2. SUNS vs CGTX Comparison

SUNS vs CGTX Comparison

Compare SUNS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.69

Market Cap

134.6M

Sector

Real Estate

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.43

Market Cap

132.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
CGTX
Founded
2023
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.6M
132.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SUNS
CGTX
Price
$9.69
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$13.50
$2.88
AVG Volume (30 Days)
94.9K
957.8K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
12.28%
N/A
EPS Growth
1112.46
N/A
EPS
1.09
N/A
Revenue
$19,384,703.00
N/A
Revenue This Year
$174.58
N/A
Revenue Next Year
$60.45
N/A
P/E Ratio
$8.95
N/A
Revenue Growth
2540.16
N/A
52 Week Low
$7.80
$0.22
52 Week High
$14.87
$3.83

Technical Indicators

Market Signals
Indicator
SUNS
CGTX
Relative Strength Index (RSI) 43.56 42.87
Support Level $10.06 $1.37
Resistance Level $10.13 $1.62
Average True Range (ATR) 0.30 0.12
MACD -0.05 -0.02
Stochastic Oscillator 33.15 15.36

Price Performance

Historical Comparison
SUNS
CGTX

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: